On Tuesday, Shares of Central Fund of Canada Limited (USA) (NYSEMKT:CEF), gained 0.28% to $10.66.
Central Fund of Canada Limited declared that Glenn Fox has been designated as Lead Director and Chair of the Corporate Governance Committee of the Board of Directors of Central Fund. Mr. Fox is an economist and has been a member of the faculty and researcher at the University of Guelph since 1985 and was named a senior research fellow of the Fraser Institute in 2013. He began serving as a director of Central Fund in February, 2015.
Mr. Fox has agreed to assume these roles at a critical time when Central Fund and its directors are facing litigation by a partner of Sprott Asset Administration LP seeking certain relief under the Business Corporations Act (Alberta), counting on grounds of oppression. Mr. Fox stated, “I am honored to play a raised role with Central Fund at this important time in its history.”
Central Fund of Canada is an closed-ended commodity mutual fund launched and managed by Central Group Alberta, Ltd. It invests in the commodity markets. The fund primarily invests in commodities like silver and gold. Central Fund of Canada was formed on November 15, 1961 and is domiciled in Canada.
Shares of Liberty Global plc - Class C Ordinary Shares (NASDAQ:LBTYK), declined -1.33% to $48.29, during its last trading session.
Liberty Global plc, declared that it has attained 138.7 million shares in ITV plc (“ITV”), thereby increasing its existing stake to a total of 398.5 million shares in ITV or about 9.9% of ITV’s ordinary shares outstanding. Liberty Global has at the same time reached a hedging transaction with respect to the ITV shares it has attained and obtained further financing from its hedge counterparty. The acquisition of the additional ITV shares, combined with amending an existing hedging transaction with respect to ITV shares, will result in net cash being released to Liberty Global.
CEO Mike Fries stated, “Given ITV’s operating and stock price performance, we were able to enhance our stake to 9.9% with no incremental investment by hedging our existing equity position. This investment remains an opportunistic one for us in our largest market. ITV is a well-run company with attractive growth potential, and we are happy to enhance our position as their largest shareholder.”
Liberty Global plc, together with its auxiliaries, provides video, broadband Internet, fixed-line telephony, and mobile services in Europe, Chile, Puerto Rico, and internationally.
At the end of Tuesday’s trade, Shares of Parsley Energy Inc (NYSE:PE), gained 2.77% to $15.58.
Parsley Energy, declared financial and operating results for the quarter ended June 30, 2015. The Company has posted to its website a presentation that supplements the information in this release.
Second Quarter 2015 Financial Highlights
Revenue for the second quarter of 2015 was $77.9 million, up 41% from Q1 2015, reflecting higher production and commodity price realizations.
During the second quarter of 2015, the Company recorded a net loss attributable to its stockholders of $19.1 million, or $0.18 per weighted average share. Not taking into account non-recurring items on a tax-adjusted basis and adding back the non-controlling interest allocated to Class B stockholders, the adjusted net loss for the second quarter of 2015 was $1.8 million, or $0.01 per diluted share. Adjusted earnings before interest, income taxes, depreciation, depletion, amortization, and exploration expense for the second quarter of 2015 was $53.4 million, up 48% contrast to the first quarter 2015.
Parsley Energy, Inc., an independent oil and natural gas company, engages in the acquisition, development, production, exploration, and sale of crude oil and natural gas properties in the Permian Basin located in West Texas and Southeastern New Mexico.
Finally, Amgen, Inc. (NASDAQ:AMGN), ended its last trade with -1.20% loss, and closed at $168.56.
Amgen, declared that its Board of Directors declared a $0.79 per share dividend for the third quarter of 2015. The dividend will be paid on Sept. 8, 2015, to all stockholders of record as of the close of business on Aug. 17, 2015.
Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses for the treatment of illness in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
